Loading...
Catastrophic ATP loss underlies a metabolic combination therapy tailored for MYCN-amplified neuroblastoma
MYCN-amplified neuroblastoma is a lethal subset of pediatric cancer. MYCN drives numerous effects in the cell, including metabolic changes that are critical for oncogenesis. The understanding that both compensatory pathways and intrinsic redundancy in cell systems exists implies that the use of comb...
Na minha lista:
| Udgivet i: | Proc Natl Acad Sci U S A |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8020796/ https://ncbi.nlm.nih.gov/pubmed/33762304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.2009620118 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|